# ADMA Biologics, Inc – FDA Inspection, Sep 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/31541623-72bc-4c97-a8d8-f7d393a56f6c
Source feed: FDA_Inspections

> FDA inspection 1219342 of ADMA Biologics, Inc, September 20, 2023. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219342
- Company Name: ADMA Biologics, Inc
- Inspection Date: 2023-09-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1256275 - 2024-12-11](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/81f31913-5145-4320-88eb-71fd5f3425fc)
- FDA Inspection 1150114 - 2021-08-12
- [FDA Inspection 1049629 - 2018-04-12](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/b5405d37-cfbd-4a12-aea8-1f51ffeecff0)
- [FDA Inspection 974061 - 2016-03-03](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/7cfce6d2-440b-4b1c-a3d4-96c2235b0b79)
- [FDA Inspection 892829 - 2014-08-14](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/dbba3019-a5fa-4567-9f08-bebe755c3f5c)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sheri-l-stephenson/dd4f3755-bb3b-4a14-a08f-8d59fbb0b6fa)

Company: https://www.keypedia.com/companies/adma-biologics-inc/dcb996fb-4a71-44fe-87f1-cfe3979d4182

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
